Hasnyálmirigyrák: vizsgálatok itt: Hollandia
49 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
- Where
- Amsterdam, Maastricht, Zwolle
- Életkor
- 18 év and over
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 · EU 2025-524160-38-00 - 2. fázisTaking peopleBelzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Where
- Utrecht
- Életkor
- 12 év and over
- People
- 355 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00 - 3. fázisTaking peopleStudy of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
- Where
- Nijmegen
- Életkor
- 18 év and over
- People
- 670 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT07621718 - 1. fázisTaking peopleA Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Where
- Amsterdam, Maastricht, Nijmegen, Utrecht
- Életkor
- 18 év and over
- People
- 340 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07213791 · EU 2025-521887-37-00 - 2/3. fázisTaking peopleZanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Where
- Amsterdam, Maastricht, Veldhoven
- Életkor
- 18 év and over
- People
- 440 worldwide
- Run by
- Exelixis
See details and how to joinNCT06943755 · EU 2025-521043-20-00 - 3. fázisTaking peopleA Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Where
- Amsterdam, Eindhoven, Groningen, Maastricht, Utrecht
- Életkor
- 18 év and over
- People
- 588 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07522073 - 1/2. fázisTaking peopleA Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- Where
- Amsterdam, Groningen, Rotterdam
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Bayer
See details and how to joinNCT06914128 · EU 2025-520623-24-00 - 3. fázisTaking peopleTiming of start of systemlc treatment for asymptomatic MEtastasized PANcreatic cancer (TIMEPAN): a prospective multicenter patient preference cohort
- Where
- Amersfoort, Amsterdam, Enschede, Harderwijk, Hoofddorp, Hoorn Nh, Leiden, Maastricht, Rotterdam, 'S-Hertogenbosch, Utrecht
- Életkor
- 18 év and over
- People
- 184
- Run by
- Amsterdam UMC
See details and how to joinNCT04897854 · EU 2023-509465-20-00 - 2. fázisTaking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Amsterdam, Groningen, Leiden, Maastricht, Nijmegen
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Amsterdam, Groningen, Nijmegen, Rotterdam, Utrecht
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - 3. fázisNot yet taking people in HollandiaPhase 3 Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC 6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma
- Where
- Amsterdam, Maastricht
- Életkor
- 18 év and over
- People
- 233 worldwide
- Run by
- Revolution Medicines Inc.
See details and how to join2025-524969-24-00 · EU 2025-524969-24-00 - No phaseTaking peoplePreoperative Optimisation of Modifiable Risk Factors in Surgery of the Pancreas
- Where
- Amsterdam, Breda, Eindhoven, Enschede, Groningen, Leeuwarden, Leiden, Maastricht, Nijmegen, Rotterdam, 's-Hertogenbosch, Utrecht
- Életkor
- 18 év and over
- People
- 2575
- Run by
- Maastricht University Medical Center
See details and how to joinNCT05851534 - 1/2. fázisTaking peopleA Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- Where
- Amsterdam, Maastricht, Rotterdam, Utrecht
- Életkor
- 18 év and over
- People
- 346 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06885034 - 1. fázisNot yet taking people in HollandiaPANVIRAL: Safety, Feasibility and Immunogenicity of Intra-Tumoral ORCA-010 Oncolytic Virus Administration in Metastatic Pancreatic Cancer – A Single-Center Phase 1 Trial
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 15
- Run by
- Amsterdam UMC Stichting
See details and how to join2026-527268-33-00 · EU 2026-527268-33-00 - 3. fázisTaking peopleStudy of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Where
- Amsterdam, Nieuwegein, Rotterdam
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT07491445 · EU 2025-525088-34-00 - 3. fázisTaking peoplePhase 3 Study of Investigator Choice of Chemotherapy with or without Zoldonrasib as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma
- Where
- Amsterdam, Leeuwarden, Nijmegen
- Életkor
- 18 év and over
- People
- 281 worldwide
- Run by
- Revolution Medicines Inc.
See details and how to join2025-524928-21-00 · EU 2025-524928-21-00 - 3. fázisTaking peopleA Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)
- Where
- Amsterdam, Eindhoven, Groningen, Maastricht, Nieuwegein
- Életkor
- 18 év and over
- People
- 239 worldwide
- Run by
- Incyte Corp.
See details and how to join2025-525009-18-00 · EU 2025-525009-18-00 - 1/2. fázisTaking peopleStudy of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
- Where
- Amsterdam, Groningen, Rotterdam
- Életkor
- 18 év and over
- People
- 392 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06005493 · EU 2023-504139-42-00 - 2. fázisNot yet taking people in HollandiaA Phase 2 Study to Evaluate the Efficacy and Safety of Ampligen® Compared to Control Group / No Treatment Following FOLFIRINOX in Subjects with Locally Advanced Pancreatic Adenocarcinoma
- Where
- Rotterdam
- Életkor
- 18 év and over
- People
- 30
- Run by
- Aim Immunotech Inc.
See details and how to joinNCT05494697 · EU 2024-518627-29-00 - 1/2. fázisTaking peopleStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 534 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06128551 - 4. fázisTaking peoplePreventing postoperative complications in patients undergoing high-risk pancreatoduodenectomy with a bundle approach including hydrocortisone, ocreotide, and teres ligament patch (PANENCA): an international randomized controlled multicenter trial
- Where
- Amsterdam, Eindhoven, Enschede, Groningen, Leiden, Maastricht, Nijmegen, Rotterdam, 'S-Hertogenbosch, Utrecht, Zwolle
- Életkor
- 18 év and over
- People
- 460 worldwide
- Run by
- Amsterdam UMC Stichting
See details and how to join2024-519667-18-00 · EU 2024-519667-18-00 - 2. fázisTaking people[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
- Where
- Groningen, Nijmegen
- Életkor
- 18 év to 79 év
- People
- 71 worldwide
- Run by
- Blue Earth Diagnostics
See details and how to joinNCT07702292 · EU 2025-521983-36-00 - 1/2. fázisTaking peopleMaster protocol of TCR-modified T cell therapy targeting HLA-restricted KRAS antigen administered in adult patients with metastatic or locally advanced PDAC
- Where
- Amsterdam, Nijmegen
- Életkor
- 18 év and over
- People
- 57 worldwide
- Run by
- Anocca AB
See details and how to join2024-513900-32-00 · EU 2024-513900-32-00 - No phaseNot yet taking people in HollandiaSpleen Preservation Versus Splenectomy in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID)
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 360
- Run by
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT07799298 - 1. fázisTaking peopleAMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- Where
- Utrecht
- Életkor
- 18 év and over
- People
- 434 worldwide
- Run by
- Amgen
See details and how to joinNCT07094113